Current Report Filing (8-k)
July 29 2016 - 9:05AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported): July 29, 2016
SEMLER
SCIENTIFIC, INC.
(Exact name of registrant as specified
in its charter)
Delaware
|
|
001-36305
|
|
26-1367393
|
(State
or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
2330 NW Everett St.
Portland, Oregon
|
|
97210
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant's telephone number, including area code:
(877)
774-4211
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction
A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02. Results of Operations and Financial Condition.
On July 29, 2016, Semler Scientific, Inc.
issued a press release announcing its financial results for the second quarter ended June 30, 2016. A copy of the press release
is furnished as Exhibit 99.1 to this Form 8-K.
The information contained in this Item
2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended,
except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
The information contained in this Item
9.01 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended,
except as shall be expressly set forth by specific reference in such filing.
(d) Exhibits.
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release of Semler Scientific, Inc., dated July 29, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
SEMLER SCIENTIFIC, INC.
|
|
|
|
|
By:
|
/s/ Douglas Murphy-Chutorian
|
|
|
Name: Douglas Murphy-Chutorian
|
|
|
Title: Chief Executive Officer
|
Date: July 29, 2016